Prefer Dr Reddy's, Lupin, Cipla, Ipca Labs: Anmol Ganjoo

Anmol Ganjoo of JM Financial Institutional Securities told CNBC-TV18, "Our pecking order in the pharma space are Dr Reddy's Laboratories, Lupin and Cipla. In the midcap cpace we like Ipca Laboratories and Torrent Pharma."

At 14:20 hrs Dr Reddy's Laboratories was quoting at Rs 3,509, up Rs 74.90, or 2.18 percent. It has touched an intraday high of Rs 3,510 and an intraday low of Rs 3,373.

Cipla's trailing 12-month (TTM) EPS was at Rs 15.49 per share. (Dec, 2014). The stock's price-to-earnings (P/E) ratio was 46.30. The latest book value of the company is Rs 125.68 per share. At current value, the price-to-book value of the company was 5.71. The dividend yield of the company was 0.28 percent.